SESSION TITLE: Sepsis II
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Wednesday, October 26, 2016 at 01:30 PM - 02:30 PM
PURPOSE: New-onset atrial tachyarrhythmia in patients diagnosed with sepsis is linked to poor outcomes including increased hospitalization for heart failure, ischemic stroke and death. There are insufficient data on management of septic patients requiring vasopressors who have concomitant atrial fibrillation with rapid ventricular rate (RVR). We seek to assess the impact on patient outcomes of amiodarone use for new-onset tachyarrhythmia in septic shock.